Host immunity contributes to the anti-melanoma activity of BRAF inhibitorsDeborah A. Knight, Mark J. Smyth|Journal of Clinical Investigation|2013Cited by 270
Targeting histone acetylation dynamics and oncogenic transcription by catalytic P300/CBP inhibitionSimon J. Hogg, Ricky W. Johnstone, Hannah D. Coughlan et al.|Molecular Cell|2021Cited by 167